RFK Jr — Article I

White House Moves to Oust FDA Chief It Installed Six Months Ago

The White House is preparing to replace FDA Commissioner Marty Makary, according to the Washington Post, as the agency faces mounting internal turmoil under the broader restructuring driven by Robert F. Kennedy Jr.'s Health and Human Services portfolio.

The play here is transparent: Makary was a Kennedy-adjacent pick meant to legitimize RFK Jr.'s vaccine skepticism inside a credentialed institution. If he's being pushed out now, it means he either wasn't compliant enough or became a liability when the political cost of FDA dysfunction started showing up somewhere that mattered — drug approvals, Wall Street, Republican senators with pharma money.

Watch who replaces him. A more ideologically committed successor signals the administration is doubling down on dismantling FDA's independent scientific posture. A technocrat signals retreat. The nominee is the tell.

Source: Washington Post Politics FDA Executive RFKJr

Brief 16h ago

RFK Jr. Turns HHS Into a Litigation Backstop Against Gardasil

Bloomberg Politics reports that Robert F. Kennedy Jr. and a network of personal injury lawyers are pressing a legal campaign against Merck's Gardasil vaccine, accusing the company of 'disease mongering' to inflate sales — a charge that runs directly against decades of mainstream medical consensus on the vaccine's safety and efficacy.

The strategic read: this isn't primarily a tort story. It's an executive-branch play. Kennedy now controls public health infrastructure. Personal injury litigation that once faced an uphill regulatory environment can now proceed in a climate shaped by the very official who built the case against the product.

Who benefits: the plaintiff's bar funding this effort, and an HHS leadership that has spent years treating vaccine approval as a political grievance rather than a public-health process. The constitutional concern is downstream: when a Cabinet officer's ideological priors reshape the regulatory record, every future safety determination at FDA is compromised before it begins.

Source: Bloomberg Politics RFKJr FDA Executive